vs
哔哩哔哩（BILI）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
哔哩哔哩的季度营收约是Revvity的1.6倍（$1.3B vs $772.1M），Revvity净利率更高（12.7% vs 6.0%，领先6.8%），哔哩哔哩同比增速更快（26.2% vs 5.9%），过去两年哔哩哔哩的营收复合增速更高（27.3% vs 9.0%）
哔哩哔哩（常被网友称为“B站”）是总部位于上海的中国知名在线视频平台，用户可在平台上传、观看各类视频内容，还能发送实时弹幕与其他观众互动，是国内深受年轻群体喜爱的文化社区。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
BILI vs RVTY — 直观对比
营收规模更大
BILI
是对方的1.6倍
$772.1M
营收增速更快
BILI
高出20.3%
5.9%
净利率更高
RVTY
高出6.8%
6.0%
两年增速更快
BILI
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $772.1M |
| 净利润 | $75.7M | $98.4M |
| 毛利率 | 37.0% | — |
| 营业利润率 | 5.8% | 14.5% |
| 净利率 | 6.0% | 12.7% |
| 营收同比 | 26.2% | 5.9% |
| 净利润同比 | 143.0% | 3.9% |
| 每股收益（稀释后） | $1.14 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BILIRVTY
| Q4 25 | $1.3B | $772.1M | ||
| Q3 25 | $1.1B | $698.9M | ||
| Q2 25 | $1.0B | $720.3M | ||
| Q1 25 | $965.1M | $664.8M | ||
| Q4 24 | $1.0B | $729.4M | ||
| Q3 24 | $1.0B | $684.0M | ||
| Q2 24 | $843.1M | $691.7M | ||
| Q1 24 | $784.5M | $649.9M |
净利润BILIRVTY
| Q4 25 | $75.7M | $98.4M | ||
| Q3 25 | $65.9M | $46.7M | ||
| Q2 25 | $30.5M | $53.9M | ||
| Q1 25 | $-1.5M | $42.2M | ||
| Q4 24 | $-176.0M | $94.6M | ||
| Q3 24 | $11.4M | $94.4M | ||
| Q2 24 | $83.7M | $55.4M | ||
| Q1 24 | $-105.9M | $26.0M |
毛利率BILIRVTY
| Q4 25 | 37.0% | — | ||
| Q3 25 | 36.7% | 53.6% | ||
| Q2 25 | 36.5% | 54.5% | ||
| Q1 25 | 36.3% | 56.5% | ||
| Q4 24 | 36.2% | — | ||
| Q3 24 | 34.9% | 56.3% | ||
| Q2 24 | 29.9% | 55.7% | ||
| Q1 24 | 28.3% | 54.6% |
营业利润率BILIRVTY
| Q4 25 | 5.8% | 14.5% | ||
| Q3 25 | 4.6% | 11.7% | ||
| Q2 25 | 3.4% | 12.6% | ||
| Q1 25 | 0.2% | 10.9% | ||
| Q4 24 | -16.0% | 16.3% | ||
| Q3 24 | 0.9% | 14.3% | ||
| Q2 24 | 9.5% | 12.4% | ||
| Q1 24 | -14.5% | 6.8% |
净利率BILIRVTY
| Q4 25 | 6.0% | 12.7% | ||
| Q3 25 | 6.1% | 6.7% | ||
| Q2 25 | 3.0% | 7.5% | ||
| Q1 25 | -0.2% | 6.4% | ||
| Q4 24 | -17.5% | 13.0% | ||
| Q3 24 | 1.1% | 13.8% | ||
| Q2 24 | 9.9% | 8.0% | ||
| Q1 24 | -13.5% | 4.0% |
每股收益（稀释后）BILIRVTY
| Q4 25 | $1.14 | $0.86 | ||
| Q3 25 | $1.05 | $0.40 | ||
| Q2 25 | $0.51 | $0.46 | ||
| Q1 25 | $0.00 | $0.35 | ||
| Q4 24 | $0.21 | $0.77 | ||
| Q3 24 | $-0.03 | $0.77 | ||
| Q2 24 | $-0.20 | $0.45 | ||
| Q1 24 | $-1.80 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.7B | $919.9M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $2.2B | $7.3B |
| 总资产 | $5.9B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.62× | — |
8季度趋势，按日历期对齐
现金及短期投资BILIRVTY
| Q4 25 | $2.7B | $919.9M | ||
| Q3 25 | $2.4B | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | $1.9B | $1.1B | ||
| Q4 24 | $1.8B | $1.2B | ||
| Q3 24 | $11.7B | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $1.1B | $1.7B |
总债务BILIRVTY
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $700.3M | — | ||
| Q4 24 | $662.5M | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $684.5M | — |
股东权益BILIRVTY
| Q4 25 | $2.2B | $7.3B | ||
| Q3 25 | $2.1B | $7.4B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | $2.0B | $7.6B | ||
| Q4 24 | $1.9B | $7.7B | ||
| Q3 24 | $13.7B | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | $1.9B | $7.8B |
总资产BILIRVTY
| Q4 25 | $5.9B | $12.2B | ||
| Q3 25 | $5.6B | $12.1B | ||
| Q2 25 | — | $12.4B | ||
| Q1 25 | $4.6B | $12.4B | ||
| Q4 24 | $4.5B | $12.4B | ||
| Q3 24 | $32.0B | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | $4.2B | $13.4B |
负债/权益比BILIRVTY
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $263.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 3.47× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流BILIRVTY
| Q4 25 | $263.1M | $182.0M | ||
| Q3 25 | $283.2M | $138.5M | ||
| Q2 25 | $277.7M | $134.3M | ||
| Q1 25 | $179.4M | $128.2M | ||
| Q4 24 | $191.9M | $174.2M | ||
| Q3 24 | $2.2B | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | $88.3M | $147.6M |
自由现金流BILIRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | $174.5M | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率BILIRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | 18.1% | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度BILIRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | 0.5% | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率BILIRVTY
| Q4 25 | 3.47× | 1.85× | ||
| Q3 25 | 4.30× | 2.97× | ||
| Q2 25 | 9.11× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 195.23× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BILI
| Value-added services (VAS) | $466.4M | 37% |
| Advertising | $435.0M | 34% |
| Mobile games | $220.3M | 17% |
| Other | $80.8M | 6% |
| IP derivatives and others | $68.2M | 5% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
